Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A03849 | 33848277 | Clin Transl Gastroenterol | Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A03850 | 33847462 | Hepatol Res | Meta-analysis of the effect of sodium-glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease. | 2021 | Details |
A03851 | 33847141 | J Am Heart Assoc | Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis. | 2021 | Details |
A03853 | 33846949 | Obes Surg | Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. | 2021 | Details |
A03854 | 33845089 | J Lipid Res | The lipidome in nonalcoholic fatty liver disease: actionable targets. | 2021 | Details |
A03855 | 33844928 | Child Obes | Omega-3 Use for the Treatment of Hypertriglyceridemia, Low High-Density Lipoprotein Cholesterol Levels, and Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2021 | Details |
A03856 | 33844769 | Rev Med Chil | [The impact on metabolic and reproductive diseases of low-carbohydrate and ketogenic diets]. | 2020 | Details |
A03857 | 33844174 | Obes Surg | Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study. | 2021 | Details |
A03858 | 33844015 | Toxicol Sci | Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin. | 2021 | Details |
A03859 | 33841891 | Obes Sci Pract | Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease. | 2021 | Details |
A03860 | 33841814 | Food Sci Nutr | Functional beverages improve insulin resistance and hepatic steatosis modulating lysophospholipids in diet-induced obese rats. | 2021 | Details |
A03861 | 33841337 | Front Endocrinol (Lausanne) | Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes: A Network Meta-Analysis. | 2021 | Details |
A03862 | 33841012 | J Ginseng Res | Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. | 2020 | Details |
A03863 | 33840662 | J Oleo Sci | Coix lacryma-jobi Seed Oil Reduces Fat Accumulation in Nonalcoholic Fatty Liver Disease by Inhibiting the Activation of the p-AMPK/SePP1/apoER2 Pathway. | 2021 | Details |
A03864 | 33840072 | Curr Obes Rep | The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. | 2021 | Details |
A03865 | 33839905 | Eur J Nutr | Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study. | 2021 | Details |
A03866 | 33839281 | Biochim Biophys Acta Mol Basis Dis | Iron depletion attenuates steatosis in a mouse model of non-alcoholic fatty liver disease: Role of iron-dependent pathways. | 2021 | Details |
A03867 | 33839223 | Int J Pharm | Inositol hexanicotinate self-micelle solid dispersion is an efficient drug delivery system in the mouse model of non-alcoholic fatty liver disease. | 2021 | Details |
A03868 | 33838994 | Nutr Metab Cardiovasc Dis | Does a high intake of green leafy vegetables protect from NAFLD? Evidence from a large population study. | 2021 | Details |
A03869 | 33838673 | Nutr J | Effects of supplementation with main coffee components including caffeine and/or chlorogenic acid on hepatic, metabolic, and inflammatory indices in patients with non-alcoholic fatty liver disease and type 2 diabetes: a randomized, double-blind, placebo-controlled, clinical trial. | 2021 | Details |
A03870 | 33838230 | J Nutr Biochem | Calcium supplementation relieves high-fat diet-induced liver steatosis by reducing energy metabolism and promoting lipolysis. | 2021 | Details |
A03871 | 33838229 | J Nutr Biochem | Olive oil-derived nitro-fatty acids: protection of mitochondrial function in non-alcoholic fatty liver disease. | 2021 | Details |
A03872 | 33838175 | Food Chem Toxicol | Increased toxicity and retention of perflourooctane sulfonate (PFOS) in humanized CYP2B6-Transgenic mice compared to Cyp2b-null mice is relieved by a high-fat diet (HFD). | 2021 | Details |
A03873 | 33837926 | Endocrine | Identification of transcriptomic signatures and crucial pathways involved in non-alcoholic steatohepatitis. | 2021 | Details |
A03874 | 33837670 | Liver Transpl | Atherogenic Dyslipidemia After Liver Transplantation: Mechanisms and Clinical Implications. | 2021 | Details |
A03875 | 33837275 | Eur J Clin Nutr | Higher plain water intake is related to lower newly diagnosed nonalcoholic fatty liver disease risk: a population-based study. | 2021 | Details |
A03876 | 33836983 | J Clin Lipidol | Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. | 2021 | Details |
A03877 | 33834737 | Am J Gastroenterol | Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites. | 2021 | Details |
A03878 | 33834607 | Liver Transpl | Reduction of Visceral Adiposity as a Predictor for Resolution of Nonalcoholic Fatty Liver in Potential Living Liver Donors. | 2021 | Details |
A03880 | 33834008 | Can J Gastroenterol Hepatol | Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use? | 2021 | Details |
A03881 | 33833974 | Pediatr Gastroenterol Hepatol Nutr | Vitamin D Effect on Ultrasonography and Laboratory Indices and Biochemical Indicators in the Blood: an Interventional Study on 12 to 18-Year-Old Children with Fatty Liver. | 2021 | Details |
A03882 | 33833819 | Evid Based Complement Alternat Med | The Exploration of Novel Pharmacophore Characteristics and Multidirectional Elucidation of Structure-Activity Relationship and Mechanism of Sesquiterpene Pyridine Alkaloids from Tripterygium Based on Computational Approaches. | 2021 | Details |
A03883 | 33833538 | Diabetes Metab Syndr Obes | The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan. | 2021 | Details |
A03884 | 33833450 | Nat Rev Cardiol | Global epidemiology of dyslipidaemias. | 2021 | Details |
A03886 | 33833347 | Sci Rep | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. | 2021 | Details |
A03887 | 33832846 | Z Med Phys | Towards detection of inflammation in adipose tissue: Microscopic field simulations to estimate water signal properties. | 2021 | Details |
A03888 | 33832643 | Maturitas | Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations. | 2021 | Details |
A03889 | 33832488 | Cell Commun Signal | Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin. | 2021 | Details |
A03890 | 33832334 | Hum Exp Toxicol | Perinatal exposure to di-(2-ethylhexyl) phthalate induces hepatic lipid accumulation mediated by diacylglycerol acyltransferase 1. | 2021 | Details |
A03891 | 33831691 | Phytomedicine | Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. | 2021 | Details |
A03892 | 33831474 | Adv Drug Deliv Rev | Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. | 2021 | Details |
A03893 | 33830112 | Mymensingh Med J | Study on Alanine Aminotransferase in Patients of Type 2 Diabetes Mellitus. | 2021 | Details |
A03894 | 33829728 | Minerva Gastroenterol (Torino) | Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease. | 2021 | Details |
A03895 | 33829368 | Adv Ther | Perspectives on Precision Medicine Approaches to NAFLD Diagnosis and Management. | 2021 | Details |
A03896 | 33827700 | BMC Pharmacol Toxicol | The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism. | 2021 | Details |
A03900 | 33826669 | PLoS One | Two-dimensional shear wave elastography and ultrasound-guided attenuation parameter for progressive non-alcoholic steatohepatitis. | 2021 | Details |
A03901 | 33825721 | Clin Transl Gastroenterol | Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease Using Noninvasive Tests From Primary Care and Endocrinology Real-World Practices. | 2021 | Details |
A03902 | 33824932 | Transl Gastroenterol Hepatol | Undiagnosed liver diseases. | 2021 | Details |
A03903 | 33824675 | Evid Based Complement Alternat Med | Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota. | 2021 | Details |
A03905 | 33824248 | Korean J Gastroenterol | Efficacy and Safety of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycholic Acid Combination in Chronic Hepatitis Related to Metabolic Syndrome Components. | 2021 | Details |
A03906 | 33824122 | Pak J Pharm Sci | Antioxidant characteristics and hepatoprotective effects of a formula derived from Maydis stigma, Nelumbo nucifera and Taraxacum officinale against carbon tetrachloride-induced hepatic damage in rats. | 2020 | Details |
A03907 | 33823622 | Angiology | Evaluation of the Impact of Ranolazine Treatment on Liver Function Tests in Patients With Coronary Heart Disease and Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A03908 | 33823088 | J Pediatr Endocrinol Metab | Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity. | 2021 | Details |
A03909 | 33822817 | PLoS One | The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD). | 2021 | Details |
A03910 | 33822497 | Int J Med Mushrooms | Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review). | 2021 | Details |
A03911 | 33822317 | Hepatol Int | Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait. | 2021 | Details |
A03912 | 33822104 | J Pharm Pharmacol | Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats. | 2021 | Details |
A03913 | 33821832 | Clin Transl Gastroenterol | Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study. | 2021 | Details |
A03914 | 33820884 | Gut Liver | Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels. | 2021 | Details |
A03915 | 33820503 | Mini Rev Med Chem | Mechanism of Natural Drugs on Nonalcoholic Fatty Liver Disease. | 2021 | Details |
A03916 | 33818707 | Jpn J Radiol | The correlation between hepatic fat fraction evaluated by dual-energy computed tomography and high-risk coronary plaques in patients with non-alcoholic fatty liver disease. | 2021 | Details |
A03917 | 33818404 | Acta Med Indones | Minimal Hepatic Encephalopathy in Patients with Alcohol Related and Non-alcoholic Steatohepatitis Related Cirrhosis by Psychometric Hepatic Cephalopathy Score and Critical Flicker Frequency. | 2021 | Details |
A03918 | 33818349 | Nutr Res Rev | Effects of betaine on non-alcoholic liver disease. | 2021 | Details |
A03919 | 33817364 | Heliyon | Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease. | 2021 | Details |
A03920 | 33817272 | Open Life Sci | Relationship of FTO gene variations with NAFLD risk in Chinese men. | 2020 | Details |
A03921 | 33816145 | World J Transplant | Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand? | 2021 | Details |
A03922 | 33816022 | Cureus | Nonalcoholic Fatty Liver Disease and Fibrosis Risk in Patients With Obstructive Sleep Apnea: A Retrospective Analysis. | 2021 | Details |
A03923 | 33815863 | World J Gastrointest Pathophysiol | Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. | 2021 | Details |
A03924 | 33815743 | Ther Adv Endocrinol Metab | Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data. | 2021 | Details |
A03925 | 33815675 | World J Hepatol | Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression. | 2021 | Details |
A03926 | 33815655 | Oxid Med Cell Longev | Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD-Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2α/CHOP Signal Pathways. | 2021 | Details |
A03927 | 33815606 | Exp Ther Med | Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study. | 2021 | Details |
A03928 | 33815296 | Front Endocrinol (Lausanne) | Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors. | 2021 | Details |
A03929 | 33815271 | Front Endocrinol (Lausanne) | Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine. | 2021 | Details |
A03930 | 33813878 | Am J Physiol Endocrinol Metab | Enoyl coenzyme A hydratase 1 alleviates nonalcoholic steatohepatitis in mice by suppressing hepatic ferroptosis. | 2021 | Details |
A03931 | 33813683 | Obes Surg | Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass. | 2021 | Details |
A03932 | 33813462 | Wiad Lek | RATIO OF MAIN PHYLOTYPES OF GUT MICROBIOTA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE BODY MASS INDEX. | 2021 | Details |
A03933 | 33813458 | Wiad Lek | RESULTS OF QUESTIONING PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN THE CONDITIONS OF DENTAL PRACTICE. | 2021 | Details |
A03934 | 33813455 | Wiad Lek | 13C-METHACETIN BREATHE TEST IN EARLY DIAGNOSTICS OF NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
A03935 | 33813276 | Biochem Biophys Res Commun | Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. | 2021 | Details |
A03936 | 33813176 | Complement Ther Clin Pract | Effects of acupoint therapy on nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2021 | Details |
A03937 | 33812253 | Int Immunopharmacol | BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization. | 2021 | Details |
A03938 | 33811766 | Hepatology | Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. | 2021 | Details |
A03939 | 33811619 | Eat Weight Disord | Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study. | 2021 | Details |
A03940 | 33811372 | J Gastroenterol Hepatol | Gut-liver-axis: Barrier function of liver sinusoidal endothelial cell. | 2021 | Details |
A03941 | 33811369 | JPEN J Parenter Enteral Nutr | Body composition measured by bioelectrical impedance analysis is a viable alternative to magnetic resonance imaging in children with nonalcoholic fatty liver disease. | 2021 | Details |
A03942 | 33811367 | Hepatology | Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial. | 2021 | Details |
A03943 | 33811139 | Proc Natl Acad Sci U S A | Active p38α causes macrovesicular fatty liver in mice. | 2021 | Details |
A03944 | 33810963 | Nutr Metab Cardiovasc Dis | Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children. | 2021 | Details |
A03945 | 33810882 | Clin Investig Arterioscler | Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway. | 2021 | Details |
A03946 | 33810609 | Int J Environ Res Public Health | Effects of Exercise on the Oral Microbiota and Saliva of Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
A03947 | 33810566 | Int J Mol Sci | Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. | 2021 | Details |
A03948 | 33810315 | Int J Environ Res Public Health | Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level. | 2021 | Details |
A03949 | 33810079 | Biomolecules | Coupling Machine Learning and Lipidomics as a Tool to Investigate Metabolic Dysfunction-Associated Fatty Liver Disease. A General Overview. | 2021 | Details |
A03950 | 33809964 | Metabolites | Stable Isotopic Tracer Phospholipidomics Reveals Contributions of Key Phospholipid Biosynthetic Pathways to Low Hepatocyte Phosphatidylcholine to Phosphatidylethanolamine Ratio Induced by Free Fatty Acids. | 2021 | Details |
A03951 | 33809676 | J Clin Med | Caspase-Cleaved Keratin 18 Measurements Identified Ongoing Liver Injury after Bariatric Surgery. | 2021 | Details |
A03952 | 33809593 | Nutrients | Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. | 2021 | Details |
A03953 | 33809062 | Mar Drugs | Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis. | 2021 | Details |
A03954 | 33808740 | Cancers (Basel) | A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? | 2021 | Details |
A03955 | 33808635 | Nutrients | Role of HO-1 against Saturated Fatty Acid-Induced Oxidative Stress in Hepatocytes. | 2021 | Details |